The Importance of Phosphate Control in Chronic Kidney Disease

Area of Science:

• Nephrology
• Endocrinology
• Mineral Metabolism

Background:

• Chronic kidney disease-mineral bone disease (CKD-MBD) encompasses osteopathy, abnormal serum data, and vascular calcification.
• Emerging factors like αKlotho and fibroblast growth factor 23 (FGF23) are clarifying CKD-MBD pathophysiology.
• Phosphate's role in CKD-MBD complications and outcomes is gaining significant attention over calcium and parathyroid hormone.

Purpose of the Study:

• To review CKD-MBD focusing on phosphorus' role.
• To explore phosphorus' involvement in CKD-MBD pathophysiology and complications.
• To discuss evidence-based therapeutic approaches for phosphorus management in CKD-MBD.

Main Methods:

• Literature review of existing clinical evidence.
• Analysis of the pathophysiology of CKD-MBD with emphasis on FGF23 and αKlotho.
• Synthesis of current understanding of phosphorus metabolism in chronic kidney disease.

Main Results:

• Phosphate metabolism and hyperphosphatemia are central to CKD-MBD.
• FGF23 and αKlotho play pivotal roles in phosphate regulation.
• Phosphate management is crucial for improving outcomes in CKD-MBD.

Conclusions:

• Phosphorus management is critical for addressing CKD-MBD.
• Understanding phosphorus' role is key to effective clinical treatment.
• This review highlights the importance of phosphorus in CKD-MBD pathophysiology and management.